Tissue Destruction by Neutrophils

New England Journal of Medicine

Volumn 320, Issue 6, 1989, Pages 365-376

  Epstein, Franklin H ^a   Weiss, Stephen J ^b  

^a University of Michigan Medical Center ^*

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL; PATHOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

ANIMAL; HUMAN; HYPOCHLOROUS ACID; INFLAMMATION; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NEUTROPHILS; OXYGEN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024602827     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198902093200606     Document Type: Review

References (86)

1. Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med 1987; 317: 687-694.
2. Henson PM, Johnston RB Jr. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 1987; 79: 669-674.
3. Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Ann Intern Med 1988; 109: 127-142.
4. Cross CE, Halliwell B, Borish ET, et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-545.
5. Halliwell B, ed. Oxygen radicals and tissue injury: proceedings of a Brook Lodge symposium, Augusta, Michigan, U.S.A., April 27 to 29, 1987. Bethesda, Md.: Federation of American Societies for Experimental Biology, 1988:1-143.
6. Weiss SJ. Oxygen, ischemia and inflammation. Acta Physiol Scand [Suppl] 1986; 548: 9-37.
7. Fridovich I. Biological effects of superoxide radical. Arch Biochem Biophys 1986; 247: 1-11.
8. Hyslop PA, Hinshaw DB. Halsey WA Jr., et al. Mechanisms of oxidant-mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988; 263: 1665-1675.
9. Test ST, Weiss SJ. Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J Biol Chem 1984; 259: 399-405.
10. Weiss SJ. The role of Superoxide in the destruction of erythrocyte targets by human neutrophils. J Biol Chem 1980; 255: 9912-9917.
11. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimeh NF. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 1981; 68: 714-721.
12. Britigan BE, Cohen MS, Rosen GM. Hydroxyl radical formation in neutrophils. N Engl J Med 1988; 318: 858-859.
13. Klebanoff SJ. Phagocytic cells: products of oxygen metabolism. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1988:391-444.
14. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J Clin Invest 1982; 70: 598-607.
15. Thomas EL, Grisham MB, Jefferson MM. Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J Clin Invest 1983; 72: 441-454.
16. Foote CS, Goyne TE, Lehrer RI. Assessment of chlorination by human neutrophils. Nature 1983; 301: 715-716.
17. Test ST, Weiss SJ. The generation of utilization of chlorinated oxidants by human neutrophils. Adv Free Radical Biol Med 1986; 2: 91-116.
18. Kanofsky J.R., Wright J, Miles-Richardson GE, Tauber AI. Biochemical requirements for singlet oxygen production by purified human myeloperoxidase. J Clin Invest 1984; 74: 1489-1495.
19. Weiss SJ, Lampert MB, Test ST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983; 222: 625-628.
20. Test ST, Lampert MB, Ossanna PJ, Thoene JG, Weiss SJ. Generation of nitrogen-chlorine oxidants by human phagocytes. J Clin Invest 1984; 74: 1341-1349.
21. Grisham MB, Jefferson MM, Melton DF, Thomas EL. Chlorination of endogenous amines by isolated neutrophils: ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem 1984; 259: 10404-10413.
22. Nathan CF. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-1560.
23. Clark RA. Extracellular effects of the myeloperoxidase-hydrogen peroxide-halide system. Adv Inflamm Res 1983; 5: 107-146.
24. Weiss SJ, Slivka A. Monocyte and granulocyte-mediated tumor cell destruction: a role for the hydrogen peroxide-myeloperoxidase-chloride system. J Clin Invest 1982; 69: 255-262.
25. Thomas EL, Learn DB, Jefferson MM, Weatherred W. Superoxide-dependent oxidation of extracellular reducing agents by isolated neutrophils. J Biol Chem 1988; 263: 2178-2186.
26. Kettle AJ, Winterbourn CC. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J 1988; 252: 529-536.
27. Albrich JM, Gilbaugh JH III, Callahan KB, Hurst JK. Effects of the putative neutrophil-generated toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli. J Clin Invest 1986; 78: 177-184.
28. Grisham MB, Jefferson MM, Thomas EL. Role of monochloramine in the oxidation of erythrocyte hemoglobin by stimulated neutrophils. J Biol Chem 1984; 259: 6757-6765.
29. Dakin HD. On the use of certain antiseptic substances in the treatment of infected wounds. Br Med J 1915; 2: 318-320.
30. Dakin HD, Dunham EK. A handbook of antiseptics. New York: Macmillan, 1918.
31. Carrel A, Dehelly G. The treatment of infected wounds. New York: Paul B. Hoebber, 1917.
32. Smith JL, Drennan AM, Rettie T, Campbell W. Experimental observations on the antiseptic action of hypochlorous acid and its application to wound treatment. Br Med J 1915; 2: 129-136.
33. Hypochlorous acid in surgery. Br J Med 1916; 1: 171-172.
34. Bashford EF. Sterilisation by Dakin's solution and the occurrence of secondary haemorrhage. Lancet 1917; 2: 595-597.
35. Taylor HD, Austin JH. The solvent action of antiseptics on necrotic tissue. J Exp Med 1918; 27: 155-164.
36. Dakin HD. The behaviour of hypochlorites on intravenous injection and their action on blood serum. Br Med J 1916; 1: 852-854.
37. Dakin HD, Cohen JB, Kenyon J. Studies in antiseptics (II): on chloramine: its preparation, properties, and use. Br Med J 1916; 1: 160-162.
38. Dakin HD, Lee WE, Sweet JE, Hendrix BM. Le Conte RG. A report of the use of dichloramin-T (toluene-parasulphondi-chloramin) in the treatment of infected wounds. JAMA 1917; 69: 27-30.
39. Johnson KJ, Fantone JC III, Kaplan J, Ward PA. In vivo damage of rat lungs by oxygen metabolites. J Clin Invest 1981; 67: 983-993.
40. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ. New mechanism for glomerular injury: myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 1987; 79: 1379-1387.
41. Gapany-Gapanavicius M, Molho M, Tirosh M. Chloramine-induced pneumonias from mixing household cleaning agents. Br Med J 1982; 285: 1086.
42. Henson PM, Henson JE, Fitlschen C, Kimani G, Bratton DL, Riches DWH. Phagocytic cells: degranulation and secretion. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1988:363-380.
43. Hay ED, ed. Cell biology of the extracellular matrix. New York: Plenum Press, 1981.
44. Vracko R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol 1974; 77: 314-346.
45. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709.
46. Weiss SJ, Peppin GJ. Collagenolytic metalloenzymes of the human neutrophil: characteristics, regulation and potential function in vivo. Biochem Pharmacol 1986; 35: 3189-3197.
47. Schalkwijk J, van den Berg WB, van de Putte LBA, Joosten LAB, van den Bersselaar L. Cationization of catalase, peroxidase, and Superoxide dismutase: effect of improved intraarticular retention on experimental arthritis in mice. J Clin Invest 1985; 76: 198-205.
48. Rehan A, Wiggins RC, Kunkel RG, Till GO, Johnson KJ. Glomerular injury and proteinuria in rats after intrarenal injection of cobra venom factor: evidence for the role of neutrophil-derived oxygen free radicals. Am J Pathol 1986; 123: 57-66.
49. Hatherill J.R., Till GO, Bruner LH, Ward PA. Thermal injury, intravascular hemolysis, and toxic oxygen products. J Clin Invest 1986; 78: 629-636.
50. Janoff A. Elastase in tissue injury. Annu Rev Med 1985; 36: 207-216.
51. Opie EL. Intracellular digestion: the enzymes and anti-enzymes concerned. Physiol Rev 1922; 2: 552-585.
52. Opie Solution of tissue with abscess. J Exp Med 1906; 8: 536-541.
53. Weiss SJ, Regiani S. Neutrophils degrade subendothelial matrices in the presence of alpha-1 -proteinase inhibitor: cooperative use of lysosomal proteinases and oxygen metabolites. J Clin Invest 1984; 73: 1297-1303.
54. Weiss SJ, Curnutte JT, Regiani S. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Immunol 1986; 136: 636-641.
55. Bruch M, Bieth JG. Influence of elastin on the inhibition of leucocyte elastase by α1-proteinase inhibitor and bronchial inhibitor: potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J 1986; 238: 269-273.
56. Kramps JA, Van Twisk C, Dijkman JH. Oxidative inactivation of bronchial antileukoprotease by triggered polymorphonuclear leukocytes. Am Rev Respir Dis 1987; 135: 290. abstract.
57. Campbell EJ, Campbell MA. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J Cell Biol 1988; 106: 667-676.
58. Ossanna PJ, Test ST, Matheson NR, Regiani S, Weiss SJ. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. J Clin Invest 1986; 77: 1939-1951.
59. Opie EL. The transformation of sero-fibrinous into purulent pleurisy. J Exp Med 1907; 9: 414-427.
60. Wasil M, Halliwell B, Hutchison DC, Baum H. The antioxidant action of human extracellular fluids: effect of human serum and its protein components on the inactivation of alpha-1-antiproteinase by hypochlorous acid and by hydrogen peroxide. Biochem J 1987; 243: 219-223.
61. Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985; 227: 747-749.
62. Peppin GJ, Weiss SJ. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA 1986; 83: 4322-4326.
63. Shah SV, Baricos WH, Basci A. Degradation of human glomerular basement membrane by stimulated neutrophils: activation of a metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest 1987; 79: 25-31.
64. Okada Y, Watanabe S, Nakanishi I, et al. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 1988; 229: 157-160.
65. Virca GD, Metz G, Schnebli HP. Similarities between human and rat leukocyte elastase and cathepsin G. Eur J Biochem 1984; 144: 1-9.
66. Schraufstatter IU, Revak SD, Cochrane CG. Proteases and oxidants in experimental pulmonary inflammatory injury. J Clin Invest 1984; 73: 1175-1184.
67. Sinha U, Sinha S, Janoff A. Characterization of sheep alpha-1-proteinase inhibitor: important differences from the human protein. Am Rev Respir Dis 1988; 137: 558-563.
68. Cantin AM, North SL, Fells GA, Hubbard RC, Crystal RG. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79: 1665-1673.
69. Velvart M, Fehr K. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol Int 1987; 7: 195-202.
70. Weiland JE, Garcia JG, Davis WB, Gadek JE. Neutrophil collagenase in rheumatoid interstitial lung disease. J AppI Physiol 1987; 62: 628-633.
71. Edwards SW, Hughes V, Barlow J, Bucknall R. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. Biochem J 1988; 250: 81-85.
72. Damiano VV, Tsang A, Kucich U, et al. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986; 78: 482-493.
73. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome: evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 1983; 71: 754-761.
74. Weiss SJ, Test ST, Eckmann CM, Roos D, Regiani S. Brominating oxidants generated by human eosinophils. Science 1986; 234: 200-203.
75. Kanofsky Jr., Hoogland H, Wever R, Weiss SJ. Singlet oxygen production by human eosinophils. J Biol Chem 1988; 263: 9692-9696.
76. Hubbard RC, Ogushi F, Fells GA, et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of α 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987; 80: 1289-1295.
77. Desrochers PE, Weiss SJ. Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase. J Clin Invest 1988; 81: 1646-1650.
78. Lawrence DA, Loskutoff DJ. Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry 1986; 25: 6351-6355.
79. Brower MS. Harpel PC. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J Biol Chem 1982; 257: 9849-9854.
80. Barbey-Morel C, Pierce JA, Campbell EJ, Perlmutter DH. Lipopolysaccharide modulates the expression of alpha 1 proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages. J Exp Med 1987; 166: 1041-1054.
81. Stendahl O, Molin L, Dahlgren C. The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone: a possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest 1978; 62: 214-220.
82. Cuperus RA, Hoogland H. Wever R, Muijsers AO. The effect of D-penicillamine on myeloperoxidase: formation of compound III and inhibition of the chlorinating activity. Biochim Biophys Acta 1987; 124-131.
83. Doherty JB, Ashe BM, Argenbright LW, et al. Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase. Nature 1986; 322: 192-194.
84. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986; 83: 6692-6696.
85. Rosenberg S, Barr PJ, Najarian RC, Hallewell RA. Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin. Nature 1984; 312: 77-80.
86. Courtney M, Jallat S, Tessier L-H, Benavente A, Crystal RG, Lecocq J-P. Synthesis in E. coli of α1-antitrypsin variants of therapeutic potential for emphysema and thrombosis. Nature 1985; 313: 149-151.